1 | MAGEA2, MAGEA3, MAGEB2, MAGEC2, NXF2
|
| Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes.
|
| Van Tongelen A, Loriot A, De Smet C.
|
| Cancer Lett. Jun 28;396:130-137. doi: 10.1016/j.canlet.2017.03.029. Epub 2017 Mar 22 2017
|
2 | MAGEB2
|
| The DNA demethylating agent 5-aza-2'-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells.
|
| Almstedt M, Blagitko-Dorfs N, Duque-Afonso J, Karbach J, Pfeifer D, Jäger E, Lübbert M.
|
| Leuk Res 34(7):899-905. Epub 2010 Apr 10.
2010
|
3 | MAGEB2
|
| MAGE-B2 autoantibody: a new biomarker for pediatric systemic lupus erythematosus.
|
| Hoftman AD, Tai LQ, Tze S, Seligson D, Gatti RA, McCurdy DK.
|
| J Rheumatol 35(12):2430-8. Epub 2008 Nov 1.
2008
|
4 | MAGEB2
|
| Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes.
|
| Milutinovic S, D'Alessio AC, Detich N, Szyf M.
|
| Carcinogenesis 28(3):560-71. Epub 2006 Sep 28.
2007
|
5 | MAGEB1, MAGEB2
|
| Hypertonicity induction of melanoma antigen, a tumor-associated antigen.
|
| Park JH, Lee SW.
|
| Mol Cells 13(2):288-95. 2002
|
6 | MAGEB@, MAGEB1, MAGEB2, MAGEB3, MAGEB4
|
| Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins.
|
| Lurquin C, De Smet C, Brasseur F, Muscatelli F, Martelange V, De Plaen E, Brasseur R, Monaco AP, Boon T.
|
| Genomics 46(3):397-408. 1997
|
7 | AHC, DSS, MAGEB1, MAGEB2, NR0B2
|
| A family of rapidly evolving genes from the sex reversal critical regionin Xp21.
|
| Dabovic B, et al.
|
| Mamm Genome 6 : 571-580. 1995
|